Bill116th CongressFiled Mar 19, 2020Health
S. 3537
Protecting Our Pharmaceutical Supply Chain from China Act of 2020
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in senate (Mar 19, 2020)
Protecting Our Pharmaceutical Supply Chain from China Act of 2020
This bill requires the federal government to maintain a registry of certain foreign-sourced drugs, prohibits federal health care programs from purchasing drugs containing Chinese ingredients, requires drugs to be labeled for country of origin, and offers domestic manufacturing facility tax incentives.
What just happenedMar 19, 2020
Read twice and referred to the Committee on Finance.
Who’s behind it
Sen. Cotton, Tom [R-AR](R-AR)Sponsor
2 cosponsors2 R
2cosponsors1committees2actions2related bills16subjects
- Introduced in SenateMar 19, 2020
- Mar 19, 2020IntroReferral
Read twice and referred to the Committee on Finance.
Finance Committee - Mar 19, 2020IntroReferral10000
Introduced in Senate